Table 1

Changes in the prevalence of gastric and oesophageal lesions before and after mass eradication of Helicobacter pylori infection

Outcome variableBefore chemopreventionAfter chemoprevention
Number of population1762841
 Gastric atrophy1056 (59.9)115 (13.7)
 Intestinal metaplasia558 (31.7)327 (38.9)
 Indefinite for dysplasia142 (8.1)128 (15.2)
 Low-grade dysplasia6 (0.3)17 (2.0)
 High-grade dysplasia0 (0)0 (0)
 Active peptic ulcer193 (11.0)30 (3.6)
 Reflux oesophagitis241 (13.7)230 (27.3)
  Los Angeles grade A177 (10.0)181 (21.5)
  Los Angeles grade B58 (3.3)38 (4.5)
  Los Angeles grade C6 (0.3)10 (1.2)
  Los Angeles grade D0 (0)1 (0.1)
 Barrett's oesophagus0 (0)2 (0.2)
  • Values are number (%).